The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1975, 114: 1808-1812.
Copyright © 1975 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gordon, J.
Right arrow Articles by Tomasi, T. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gordon, J.
Right arrow Articles by Tomasi, T. B., Jr.

The Immune Response of Mice Treated with Anti-µ Antibodies: The Effect on Antibody-Forming Cells, Their Precursors and Helper Cells Assayed in Vitro1

Julius Gordon2, Robert A. Murgita3 and Thomas B. Tomasi, Jr.3

From the Department of Immunology, Mayo Medical School, Mayo Clinic, Rochester, Minnesota 55901

Abstract

Previous studies have shown that mice treated from birth with heterologous anti-µ antiserum are severely immuno-suppressed with respect to numbers of splenic plaque-forming cells (PFC) to sheep red blood cells (SRBC) in all immunoglobulin classes. In this study we have investigated, using in vitro techniques, the cellular site of the deficit created by anti-µ. The primary PFC response of spleen cells originating from anti-µ-treated mice was completely suppressed in vitro. The response was restored by the addition to the cultures of B cells but not T cells. T cells were derived from normal spleens which had been depleted of B lymphocytes and adherent cells by filtration through cotton wool columns, or by educated thymus cells obtained from the spleens of lethally irradiated mice injected with syngeneic thymocytes and SRBC.

Restoration of the PFC response of spleen cells from anti-µ-treated mice by normal B cells suggested that a cellular deficiency rather than an activity process by inhibitory cells was the cause of the imunosuppression. Also, co-culturing spleen cells from normal and suppressed mice did not reveal the presence of inhibitory cells. Spleen cells from x-irradiated mice, injected with bone marrow from anti-µ-suppressed mice, gave rise to PFC cells when cultured with SRBC and normal T cells, suggesting that stem cells giving rise to B cells were not affected by anti-µ treatment. Similarly, educated thymus cells derived from suppressed mice could provide helper function when reconstituted in vitro with normal B cells. Exposure of normal bone marrow and spleen cells to anti-µ serum prior to passage through syngeneic x-irradiated recipients demonstrated that spleen cells were much more sensitive than were bone marrow cells to suppression by anti-µ antibodies. It is concluded that the target of anti-µ antibody is a µ-chain bearing B cell precursor to the IgM-, IgG-, and IgA-producing cell.

Footnotes

1 Supported by grants from the Medical Research Council of Canada and Public Health Research Grant 5 RO 1 AM 17554.

2 Research Associate of the Medical Research Council of Canada, Department of Surgery, Division of Surgical Research, Donner Building, McGill University, Montreal, Quebec, Canada.

3 Department of Immunology, Mayo Medical School, Rochester, Minnesota 55901.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1975 by The American Association of Immunologists, Inc. All rights reserved.